Urethral Dilators Market Outlook:
Urethral Dilators Market size was valued at USD 271.54 million in 2025 and is likely to cross USD 500.23 million by 2035, expanding at more than 6.3% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of urethral dilators is assessed at USD 286.94 million.
The reason behind the growth is impelled by the increasing prevalence of chronic kidney disorders. The prevalence of chronic kidney disease (CKD) has been identified as a major global public health issue, which is majorly caused by stress, and hypertension in all high- and middle-income nations.
Chronic kidney diseases can result in various urological conditions, which involve the use of urethral dilators. Chronic kidney disease (CKD) affects more than 8% of people globally, and millions of people pass away each year because they lack access to effective treatment.
The rising popularity of minimally invasive procedures are believed to fuel the market growth. The popularity of minimally invasive surgery among patients has grown owing to its advantages such as smaller incisions, less discomfort, and shorter hospital stay.
Urethral dilation is a minimally invasive procedure for the treatment of bulbar urethral strictures where a permanent catheter is used to drain the bladder, which offers a faster recovery, and minimal scarring.